CoMentis has a total of 112 patents globally, out of which 23 have been granted. Of these 112 patents, more than 3% patents are active. United States of America is where CoMentis has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of CoMentis.
CoMentis founded in 2006, CoMentis Inc is a biotechnology company focused on discovering and developing small-molecule drugs for CNS and neurovascular disorders. The company develops therapies targeting conditions such as Alzheimer’s disease, age-related macular degeneration, and other cognitive disorders. Originally founded as Athenagen in 2004, the company was renamed CoMentis following its 2006 merger with Zapaq, creating a neurovascular-focused drug development business.
Do read about some of the most popular patents of CoMentis which have been covered by us in this article and also you can find CoMentis patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CoMentis patent portfolio.
How many patents does CoMentis have?
CoMentis has a total of 112 patents globally. These patents belong to 13 unique patent families. Out of 112 patents, 3 patents are active.
How Many Patents did CoMentis File Every Year?
| Year of Patents Filing or Grant | CoMentis Applications Filed | CoMentis Patents Granted |
| 2017 | – | 1 |
| 2016 | – | 1 |
| 2015 | 3 | 2 |
| 2014 | 4 | – |
| 2013 | 13 | 1 |
| 2012 | – | 5 |
| 2011 | 4 | 3 |
| 2010 | 10 | 6 |
| 2009 | 10 | 2 |
| 2008 | 25 | 2 |
How many CoMentis patents are Alive/Dead?
Worldwide Patents
How Many Patents did CoMentis File in Different Countries?
Countries in which CoMentis Filed Patents
| Country | Patents |
| United States of America | 14 |
| Europe (EPO) | 12 |
| Japan | 11 |
| Canada | 9 |
| Australia | 7 |
| Mexico | 6 |
| China | 6 |
| Korea (South) | 6 |
| India | 6 |
| Singapore | 3 |
| Hong Kong (S.A.R.) | 3 |
| Brazil | 3 |
| Argentina | 2 |
| Taiwan | 2 |
| South Africa | 2 |
| New Zealand | 2 |
| Eurasia | 1 |
| Austria | 1 |
| Italy | 1 |
| Hungary | 1 |
| Israel | 1 |
Where are Research Centres of CoMentis Patents Located?
The Research Centre for all the CoMentis patents is the United States of America.
10 Best CoMentis Patents
WO2006034277A1 is the most popular patent in the CoMentis portfolio. It has received 69 citations so far from companies like Schering Corporation.
Below is the list of 10 most cited patents of CoMentis:
| Publication Number | Citation Count |
| WO2006034277A1 | 69 |
| WO2009042694A1 | 37 |
| WO2012054510A1 | 27 |
| WO2006110668A1 | 24 |
| US20070167526A1 | 18 |
| US7335632B2 | 14 |
| US20060234944A1 | 13 |
| WO2011130383A1 | 11 |
| WO2009046025A1 | 11 |
| WO2010042892A1 | 10 |
What Percentage of CoMentis US Patent Applications were Granted?
CoMentis (Excluding its subsidiaries) has filed 22 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 50.0%.
Below are the key stats of CoMentis patent prosecution at the USPTO.
Which Law Firms are managing US Patents for CoMentis?
| Law Firm | Total Applications | Success Rate |
| Morrison & Foerster Llp | 21 | 53.33% |
| Vlp Law Group Llp | 1 | 0.00% |
What are CoMentis key innovation segments?
What Technologies are Covered by CoMentis?
The chart below distributes patents filed by CoMentis